Reflectance Confocal Microscopy Improves Clinicopathologic Correlation in Facial Lentigo Maligna: A Prospective Real-Life Study
In brief
Confocal microscopy spared 75% of suspected facial lentigo maligna lesions from biopsy
In a prospective single-center study of 248 flat pigmented facial lesions, reflectance confocal microscopy had 100% sensitivity and 94.2% specificity for lentigo maligna; 187 lesions did not undergo biopsy after imaging. One in five confirmed cases had an initially negative biopsy, so imaging findings still need careful follow-up and, when suspicious, further tissue evaluation. The results need validation beyond one center and depend on operator interpretation.
- Journal
- Journal of the American Academy of Dermatology (Q1)
- Published
- 19 November 2026
- Study design
- Unclassified
- Evidence level
- Level 5, Expert Opinion (CEBM 5)
- Authors
- Marianne Thérèse Signoret-Bravo, David Eduardo Isla, Ernesto Jaramillo-Agüero, Josefina Gazmuri, Sebastián González-Valdés, Sergio Bustos, et al.
- PMID
- 43057478
- DOI
- 10.1016/j.jaad.2026.11.047
Why clinicians should know about it
- Picked for Dermatology (paper of the day, 22 November 2026): Prospective study of RCM for facial lentigo maligna diagnosis
Abstract
BACKGROUND: Pigmented facial lesions pose a diagnostic challenge, and lentigo maligna (LM) must not be overlooked as a differential diagnosis. Despite integrated evaluation with clinical examination and dermoscopy, diagnostic uncertainty may persist. Reflectance confocal microscopy (RCM) has emerged as a complementary diagnostic tool. OBJECTIVE: To assess the diagnostic performance of RCM in clinically suspected cases of facial LM. METHODS: We conducted a prospective single-center study between February 2021 and September 2025, including 248 flat pigmented facial lesions clinically suspected of LM. RCM was performed, and lesions suggestive of LM were biopsied. Results were compared with the gold standard, defined as the diagnosis obtained after integrated clinical-dermoscopic-RCM-histopathological evaluation. RESULTS: RCM achieved 100% sensitivity and 94.2% specificity for LM diagnosis, and 75% (n = 187) of lesions did not undergo biopsy following RCM evaluation. Perifollicular dendritic cells on RCM were present in 100% of biopsy-proven LM. Among all LM, 20% had an initially negative biopsy despite RCM findings suggestive of LM, prompting additional histopathological evaluation that ultimately confirmed LM in all cases. LIMITATIONS: Single-center real-world study, limited to facial lesions, potential underestimation of false negatives and operator-dependent interpretation. CONCLUSION: RCM strengthens the correlation between clinical, dermoscopic, and histopathologic findings in LM.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.